Monogram Technologies Inc (MGRM) - Forward Price-to-Revenue Multiple
How does the diversification of Monogram Technologies (MGRM) robot components impact margins? This chart on GURU.Markets displays the trend via a forward P/S indicator, where 299.60 represents the current metric value. Specialized rigging delivery ensures system reliability. Meanwhile, independence from macroeconomic factors and the demand for innovation transform the asset into a defensive tool.
Monogram Orthopedics Inc. - analytical breakdowns and key metrics (MGRM)
- market price and analyst price targets:
- market capitalization indicators:
- business book valuation details:
- issuer credit burden and liquidity indicators:
Debt to Equity Monogram Technologies|MGRM - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio Monogram Technologies|MGRM - Company Cumulative Indebtedness|Debt to Book Capitalization Ratio Monogram Orthopedics Inc.|MGRM - Long-Term Debt Volume|Company Short-Term Debt Monogram Orthopedics|Quick Liquidity monogramorthopedics.com
- business earnings and investment ratios data:
MGRM - Company Net Income|Expected Profit Monogram Technologies|MGRM - Price to Earnings Multiple|Future Price to Earnings Monogram Technologies Inc|MGRM - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple Monogram Orthopedics Inc.|MGRM - Operating profit before depreciation charges|Earnings per share for the last twelve months Monogram Orthopedics|MGRM - Earnings per share for the trailing year|Quarterly EPS earnings growth monogramorthopedics.com|MGRM - Earnings growth in current year|Net earnings per share growth forecast for next year Monogram Technologies
- sales and revenue data:
General company analysis:MGRM (Monogram Orthopedics)
The forward P/S ratio compares the current market value of Monogram Technologies (MGRM) with expected revenue for the coming year, allowing for an assessment of the premium paid for future growth. This forward P/S indicator demonstrates the company's ability to scale sales of robotic orthopedic systems and pass costs onto clinics, helping investors distinguish an undervalued asset from a value trap during periods of stagnation.
Analysis of competing companies
Price-to-Projected Revenue Ratio Intuitive ISRG|Forward Price to Sales DHR|BDX: Forward Price-to-Revenue Multiple|STE - Forward P/S Multiple|West Pharmaceutical Services (WST) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple baxter.com|MASI (Masimo) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Stevanato Group SpA STVN|Price-to-Projected Revenue Ratio Teleflex Inc (TFX)|Merit Medical Corp - Market Cap to Projected Revenue|Envista Holdings - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio ICUI (icumed.com)|XRAY - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio LeMaitre Vascular Inc LMAT|AtriCure Corp (ATRC) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple STAAR Surgical Co|Price-to-Projected Revenue Ratio ChromaDex Corporation|Market Cap to Future Revenue Ratio zimvie.com ZIMV|Price-to-Projected Revenue Ratio AngioDynamics (ANGO)|Cerus Corp. - Market Cap to Projected Revenue|Price-to-Projected Revenue Ratio Alpha Teknova Inc TKNO|Sharps Technology Inc (STSS) - Market Cap to Future Revenue Ratio|InfuSystem Inc - Forward P/S Multiple|Projected Price to Revenue utahmed.com (UTMD)|korumedical.com (KRMD) - Price-to-Projected Revenue Ratio|Nyxoah SA - Forward Price to Sales|MBOT (Microbot Medical Inc) - Forward P/S Multiple|Forward P/S Multiple Pro-Dex Inc.|Price-to-Projected Revenue Ratio Zentek Ltd. (ZTEK)|Forward Price-to-Revenue Multiple elutia.com ELUT|Milestone Scientific Inc. - Forward Price-to-Revenue Multiple|Forward Price to Sales NXGL|RVP: Forward Price-to-Revenue Multiple|harvardbioscience.com - Price to Expected Revenue Ratio|FEMY: Forward P/S Multiple|Market Cap to Future Revenue Ratio Meihua Medical Technologies Co., Ltd. (MHUA)|POAI (Predictive Oncology Inc) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Callan JMB Corp (CJMB)|Forward P/S Multiple ATRI|NURO (NeuroMetrix Corporation) - Forward Price to Sales
